Open research questions in Receptor Mechanisms and Signaling
87 unresolved questions extracted from the limitations and future-work sections of 221 Receptor Mechanisms and Signaling papers in our library. Each links back to the study that raised it.
What the literature leaves open
Despite numerous available studies, many biophysical aspects that regulate G protein signaling, including membrane mobility, remain poorly understood.
Heterotrimeric G proteins containing Gβ1γ2 subunits exhibit subtype-specific mobility differences in live cells · 2026 · DOIHowever, the extent of underlying SUD causal variants, effector genes, and cellular contexts, remains unclear.
Shared and unique chromatin accessibility and 3D functional interactions of substance use disorder loci implicate cell types beyond the brain · 2026 · DOIHowever, the functional role of NK1S remains controversial; therefore, we investigated their functional interplay.
The C‐terminal truncated splicing variant of NK1R negatively modulates substance P‐stimulated NK1R signaling · 2026 · DOIHowever, the neural mechanisms mediating these effects and the role of endogenous central GLP-1 signaling in cocaine seeking remain unknown.
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking · 2025 · DOIDespite the abundant structures of GPCR–G protein complexes, little is known about the mechanism of G protein coupling specificity.
Our findings suggest that RYR1 should be further studied as a potential therapeutic target for reducing HF-related mortality.
Genetic variation in RYR1 is associated with heart failure progression and mortality in a diverse patient population · 2025 · DOIDespite its physiological significance, the mechanisms underlying H4R signalling and G protein preference across histamine receptors remain poorly understood.
Structural insights into ligand recognition and G protein preferences across histamine receptors · 2025 · DOIDespite great progress in other species, pharmacological properties of the bovine FFAR2 (bFFAR2) are not fully understood.
Although its molecular mechanism remains elusive, big efforts are made to try to explain this mechanism using a wide range of methods.
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches · 2025 · DOIThe structural properties that govern the functional selectivity and the conformational dynamics of ACKR3 activation are poorly understood.
However, the conformational basis of selective coupling of primary G‐protein remains elusive.
Molecular Determinant Underlying Selective Coupling of Primary G‐Protein by Class A GPCRs · 2024 · DOIBoth βarr and Gβγ contribute to such non-canonical endosomal G protein signaling, but their specific roles and contributions remain poorly understood.
Role of the V2R–βarrestin–Gβγ complex in promoting G protein translocation to endosomes · 2024 · DOIBased on structural homology, GPR180 is a new member of this protein family, but little is known about the cellular role of GPR180.
GPR180 is a new member of the Golgi-dynamics domain seven-transmembrane helix protein family · 2024 · DOIDespite their biological significance, GPCRs have not been widely studied in the field of toxicology.
However, studies regarding the functional selectivity of Receptor Tyrosine Kinases (RTKs) remain sparse.
Functional selectivity of Receptor Tyrosine Kinases regulates distinct cellular outputs · 2024 · DOIMuch remains to be known about the integration of different signals affecting RTK signalling specificity to orchestrate long-term cellular outcomes.
Functional selectivity of Receptor Tyrosine Kinases regulates distinct cellular outputs · 2024 · DOIAlthough α2-adrenergic receptors are known to modulate the immune response in different ways, the therapeutic exploration of their utility has been limited by the lack of agonists selective for the three α2-adrenergic subtypes.
No PAM-bound A3 AR structure is available to date. The lack of experimental A3 AR structure at the time of the study required the use of modeling calculations.
From empirical screening to lipid trolling: the evolution of extrahelical allosteric modulators of A1 and A3 adenosine receptors · 2026 · DOIThe lack of understanding of the binding sites of A1 and A3 AR PAMs. The limited development of synthetic optimization methods to modify the N4 and C2 positions on the scaffold.
From empirical screening to lipid trolling: the evolution of extrahelical allosteric modulators of A1 and A3 adenosine receptors · 2026 · DOIA specific difference in CHRM3 expression level was found in LPFC ExNs between young and aged monkeys, but larger sample sizes are needed to fully assess age-related effects on expression profiles.
Transcriptional and functional profiles of muscarinic receptor-expressing neurons in primate lateral prefrontal and anterior cingulate cortices · 2026 · DOIThe A24 ACC tissue block contains cells from two distinct cytoarchitectonic subareas (24b and 24c) which cannot be distinguished in the snRNAseq dataset.
Transcriptional and functional profiles of muscarinic receptor-expressing neurons in primate lateral prefrontal and anterior cingulate cortices · 2026 · DOIThe transient nature of calcium signals necessitates real-time monitoring with specialized equipment. Current assays have limitations for high-throughput applications.
A luminescent calcium biosensor enabling endpoint measurement of GPCR-mediated calcium signaling · 2026 · DOINo comparison with other luminescent calcium biosensors or detailed validation against established gold-standard methods beyond FLIPR is presented in the available excerpt.
A luminescent calcium biosensor enabling endpoint measurement of GPCR-mediated calcium signaling · 2026 · DOIInter-study differences limit the development of pharmacological therapies. Experimental cell systems are limited by their inability to capture crosstalk between cell types from different organs.
An Integrated Analysis of GLP-1R Agonist Mechanisms: Addressing Study Variations in Heterogeneous Cell Systems · 2026 · DOIThe development of pharmacological therapies such as GLP-1RAs is limited by study variability. Experimental cell systems can be used to study metabolic regulation and drug responses, but are limited by inter-study differences.
An Integrated Analysis of GLP-1R Agonist Mechanisms: Addressing Study Variations in Heterogeneous Cell Systems · 2026 · DOI
Most-cited papers in Receptor Mechanisms and Signaling
- High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor · Science · 2007 · 2,962 citations
- Crystal structure of the β2 adrenergic receptor–Gs protein complex · Nature · 2011 · 2,904 citations
- The structure and function of G-protein-coupled receptors · Nature · 2009 · 2,234 citations
- A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity · Science · 2006 · 2,066 citations
- Tools for GPCR drug discovery · Acta Pharmacologica Sinica · 2012 · 284 citations
- Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs · eLife · 2022 · 264 citations
- Modulation of Glucocorticoid Receptor Function via Phosphorylation · Annals of the New York Academy of Sciences · 2004 · 246 citations
- Pushing the frontiers: tools for monitoring neurotransmitters and neuromodulators · Nature reviews. Neuroscience · 2022 · 227 citations
- Community guidelines for GPCR ligand bias: IUPHAR review 32 · British Journal of Pharmacology · 2022 · 221 citations
- Structures of the entire human opioid receptor family · Cell · 2023 · 206 citations
Most recent work
- Mechanism-guided identification of antidepressant G protein-coupled receptor drug targets · Cell · 2026
- A GPCR-G protein-β-arrestin megacomplex enabled by a versatile allosteric modulator · Cell · 2026
- Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk · Blood · 2026
- Core promoters restrict pleiotropic enhancer inputs to achieve spatiotemporal specificity in gene expression · bioRxiv · 2026
- CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson’s Disease · Journal of Medicinal Chemistry · 2026
- Sulfo-DIBMA encapsulation uniquely preserves signalling-competent active states of the class B1 GPCRs, calcitonin gene-related peptide and parathyroid hormone 1 receptors, in native-like nanodiscs · bioRxiv · 2026
- GLASS2: An Updated Database for Comprehensive Experimentally Validated GPCR-ligand Associations · Journal of Molecular Biology · 2026
- Cryo-EM structures of GPR75 reveal an occluded orthosteric pocket challenging conventional drug discovery paradigms for an anti-obesity target · Acta Pharmacologica Sinica · 2026
- Biased Kappa-opioid Agonist Strategies in Pain Management: Approaches to Clinical Benefits with Reduced Adverse Effects · Drugs · 2026
- Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer · Cancer Research · 2026
Find a gap in your own Receptor Mechanisms and Signaling sub-topic
This page shows what the Receptor Mechanisms and Signaling literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.
Open the Research Gap Finder →